ORG Partners LLC Buys New Shares in Avantor, Inc. (NYSE:AVTR)

ORG Partners LLC bought a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 4th quarter, Holdings Channel reports. The firm bought 3,882 shares of the company’s stock, valued at approximately $89,000.

Several other institutional investors and hedge funds also recently bought and sold shares of AVTR. Fifth Third Bancorp lifted its position in Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares in the last quarter. Quarry LP lifted its position in shares of Avantor by 815.3% in the first quarter. Quarry LP now owns 1,437 shares of the company’s stock valued at $30,000 after acquiring an additional 1,280 shares in the last quarter. CKW Financial Group purchased a new position in shares of Avantor in the fourth quarter valued at about $55,000. Park Place Capital Corp lifted its position in shares of Avantor by 18.2% in the third quarter. Park Place Capital Corp now owns 3,039 shares of the company’s stock valued at $64,000 after acquiring an additional 467 shares in the last quarter. Finally, UniSuper Management Pty Ltd purchased a new position in shares of Avantor in the second quarter valued at about $99,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Trading Down 2.3 %

Shares of NYSE AVTR opened at $24.96 on Monday. The business’s 50 day moving average is $24.84 and its two-hundred day moving average is $22.36. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $26.16. The stock has a market capitalization of $16.93 billion, a P/E ratio of 52.00, a PEG ratio of 1.57 and a beta of 1.37.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The company had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.70 billion. During the same period in the previous year, the firm posted $0.32 earnings per share. The firm’s revenue for the quarter was down 4.0% on a year-over-year basis. As a group, research analysts expect that Avantor, Inc. will post 1.01 EPS for the current year.

Insiders Place Their Bets

In other Avantor news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on AVTR shares. Barclays boosted their price objective on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. JPMorgan Chase & Co. boosted their price objective on Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Royal Bank of Canada boosted their price objective on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. UBS Group boosted their price objective on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Finally, Robert W. Baird boosted their price objective on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $26.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.